International Journal of Personalized Medicine
Publishing transformative research in pharmacogenomics, molecular diagnostics, targeted therapies, biomarker discovery, and precision oncology advancing personalized treatment strategies that improve patient outcomes through individualized care based on genetic profiling molecular characteristics and predictive analytics.
What You Gain
- Comprehensive open access publication with global indexing ensuring maximum discoverability among precision medicine researchers clinicians and pharmaceutical scientists worldwide
- Permanent DOI for stable citations
- Author retains full copyright
- Free genomic data visualization
- 24hr editorial support response
Career-Changing Benefits
Tangible professional advantages when you publish your precision medicine research
From Submission to CV Citation
Transparent timeline showing your research path to publication
How Publication Accelerates Careers
Data from precision medicine researchers who published with us
Precision Medicine Topics We Publish
Comprehensive scope across personalized healthcare applications
Pharmacogenomics
CYP450 genetic variants, drug metabolism polymorphisms, adverse drug reaction prediction, warfarin dosing algorithms, clopidogrel resistance, opioid sensitivity, chemotherapy toxicity prevention personalized medication selection
Precision Oncology
Tumor mutational profiling, liquid biopsies, circulating tumor DNA, PD-L1 expression, microsatellite instability, BRCA testing, targeted therapy selection, immunotherapy biomarkers, minimal residual disease monitoring treatment response prediction
Cardiovascular Genomics
Familial hypercholesterolemia genetic screening, polygenic risk scores, sudden cardiac death prevention, cardiomyopathy variants, arrhythmia susceptibility, statin response prediction, hypertension pharmacogenomics precision prevention strategies
Rare Disease Diagnosis
Whole exome sequencing, whole genome sequencing, undiagnosed disease programs, molecular diagnosis, gene panel testing, variant interpretation, newborn screening expansion, orphan drug development precision therapy matching
Infectious Disease
HIV treatment individualization, tuberculosis drug resistance prediction, antimicrobial stewardship, sepsis biomarkers, COVID-19 severity prediction, vaccine response genetics, transplant recipient monitoring pathogen genomics
Digital Health Integration
Wearable biosensors, continuous monitoring, AI-driven risk prediction, electronic health record genomic integration, clinical decision support, telemedicine genomics, mobile health apps, patient portals precision medicine delivery
Comprehensive Support Services for Authors
Every membership includes access to our full suite of professional publication support services designed to maximize the quality and impact of your research
Professional bioinformatics support for complex genomic datasets including variant visualization, pathway enrichment plots, mutation signatures, phylogenetic trees, protein structure modeling, and multi-omic integration graphics ensuring maximum clarity and publication-ready figures that reviewers and readers can easily interpret and appreciate.
Complimentary expert review of study design, sample size calculations, multiple testing corrections, survival analysis, machine learning model validation, omics data analysis pipelines, and statistical methods ensuring appropriate methodology selection preventing reviewer critiques and strengthening conclusions supporting rapid acceptance and high citation impact.
Assistance with genomic data deposition to dbGaP, ClinVar, GEO, ArrayExpress, PDB ensuring Findable Accessible Interoperable Reusable principles met, permanent accession numbers obtained, metadata standardization, and funder requirements satisfied including funder data sharing policy compliance maximizing data reuse and secondary citations.
For breakthrough precision medicine discoveries requiring rapid dissemination including novel biomarkers, therapeutic targets, drug resistance mechanisms, or clinical trial results, we offer fast-track review with first decision in 10 days and publication within 3 weeks ensuring timely knowledge translation, citation priority, and competitive advantage in rapidly evolving personalized healthcare field.
Why Precision Medicine Leaders Choose Open Access Publishing
Membership Tiers
Select the membership tier that best supports your personalized medicine research publication goals and professional development. Each tier includes full open access publication with immediate worldwide visibility, expert peer review by genomic medicine specialists, and dedicated editorial support throughout the manuscript preparation and review process. All tiers feature complimentary language editing, figure preparation assistance, and priority correspondence with our editorial office ensuring a seamless publishing experience from initial submission through final publication
Have Questions?
Reach our editorial team for personalized membership guidance, manuscript preparation assistance, and publication timeline inquiries. Our dedicated support specialists respond within twenty-four hours to help you select the optimal membership tier for your genomic medicine research needs. We also provide guidance on manuscript formatting requirements, reference style specifications, and supplementary data preparation to streamline your submission
[email protected]Publish Your Precision Medicine Research
Submit your genomic medicine research for expert peer review and immediate global open access distribution advancing personalized healthcare and improving patient outcomes worldwide. Whether your research explores novel pharmacogenomic biomarkers, develops targeted therapeutic strategies, validates molecular diagnostic approaches, or advances precision oncology protocols, IJPM connects your discoveries with the global precision medicine research community. Our streamlined submission process and dedicated editorial team ensure rapid turnaround from manuscript receipt to final publication. Join a growing community of precision medicine researchers who trust IJPM for disseminating their most important discoveries in pharmacogenomics, molecular diagnostics, biomarker validation, and individualized therapeutic interventions to a global audience of clinicians and scientists.